Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer

NCT00005072 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Stopped Development in prostate cancer indication halted

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Leuvectin

Sponsor

Vical

Collaborators

[object Object]
[object Object]